Table 6. Histology-specific univariate associations with disease-free survival for AC (N=33) and SCC (N=26) patients.
| Metric | AC (N=33, Nevents=17) | SCC (N=26, Nevents=14) | |||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| MTV | 1.31 (0.90–1.90) | 0.16 | 0.95 (0.56–1.60) | 0.84 | |
| SUVmax | 1.45 (0.92–2.28) | 0.11 | 0.74 (0.43–1.26) | 0.26 | |
| SUVpeak | 1.48 (0.94–2.33) | 0.09 | 0.73 (0.42–1.27) | 0.27 | |
| SUVmean | 1.58 (1.02–2.44) | 0.04 | 0.74 (0.43–1.27) | 0.28 | |
| TLG | 1.50 (1.01–2.22) | 0.04 | 0.89 (0.51–1.55) | 0.69 | |
| Homogeneity | 1.08 (0.67–1.76) | 0.75 | 1.83 (1.12–2.98) | 0.02 | |
| Entropy-GLCM | 0.80 (0.5–1.29) | 0.36 | 0.56 (0.34–0.92) | 0.02 | |
| Dissimilarity | 0.88 (0.55–1.40) | 0.58 | 2.16 (1.30–3.59) | 0.003 | |
MTV, metabolic tumor volume; SUV, standardized uptake value; TLG, total lesion glycolysis; GLCM, grey-level co-occurrence matrix; AC, adenocarcinoma; SCC, squamous cell carcinoma.